NCT06729411

Brief Summary

A monocentre randomized controlled parallel (1:1) clinical trial was performed with consecutively selected individuals with diabetes and active diabetes-related foot ulcers (DFU). Participants were randomly assigned to control or treatment groups. The experimental group received MOD treatments, and the control group received 15-mm felted foam treatments. All participants wore a removable ankle-high offloading device. Primary outcome measure was the 12-week healing rate. The time to healing was evaluated during a 12-week follow-up period. The secondary outcome measures included minor or major amputations related to the DFU during a follow-up period of 6 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 7, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 11, 2024

Completed
Last Updated

December 17, 2025

Status Verified

December 1, 2024

Enrollment Period

9 months

First QC Date

December 7, 2024

Last Update Submit

December 9, 2025

Conditions

Keywords

diabetic footulcer healingoffloading deviceminimal offloading dressingfoot ulcerhealing

Outcome Measures

Primary Outcomes (1)

  • Healing rate

    Healing was defined as intact skin at the foot-ulcer site with complete epithelialization and no drainage

    12-weeks

Secondary Outcomes (3)

  • Minor amputation

    6 months

  • Major amputation

    6 months

  • Transfer lesions

    12-weeks

Study Arms (2)

The experimental group received minimal offloading dressing (MOD) treatments

EXPERIMENTAL

The MOD device was a monolayer device that can be applied directly to the participants skin via a non-irritative adhesive backing. The MOD was made of medium-density ethyl-vinyl acetate (40-45° Shore A hardness and 250-400-kg/cm2 density). The MOD is predesigned for three different locations: the first metatarsal head, central metatarsal heads, and fifth metatarsal. The MOD size ranged from size 35 to 48, which is measured according to the French system for each increase of 6.66 mm in length and 1.5 mm in width. All edges of the MOD were bevelled, and apertures were made to accommodate sites of plantar DFUs.

Device: Minimal Offloading dressing

The control group received 15-mm felted foam treatments

ACTIVE COMPARATOR

The felted padding used in the control group was made out of semi-compressed wool felt with an adhesive backing (Herbitas lab, 46134 Foios-Valencia, Spain). The padding thickness was 15 mm on the whole foot, and similar apertures to those used with the other offloading device were made to accommodate the sites of plantar ulceration.

Device: Felted foam

Interventions

The felted padding used in the control group was made out of semi-compressed wool felt with an adhesive backing (Herbitas lab, 46134 Foios-Valencia, Spain). The padding thickness was 15 mm on the whole foot, and similar apertures to those used with the other offloading device were made to accommodate the sites of plantar ulceration.

The control group received 15-mm felted foam treatments

Metatarsal minimal offloading dressings (MODs) are standard offloading devices that are gaining attention. MODs offload a specific ulcerated area and could reduce variability when applying the device onto the skin. MODs are new predesigned devices that do not require any further adaptation or clinician skills and can be directly applied to an ulcerated metatarsal head using a non-irritating adhesive.

The experimental group received minimal offloading dressing (MOD) treatments

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 1 or 2 diabetes mellitus.
  • Age \>18 years,
  • Plantar DFU with Texas classification IA or IIA.
  • Glycaemic control confirmed by a haemoglobin A1c ≤ 10% (85.8 mmol/mol) in the previous 3 months.

You may not qualify if:

  • Critical limb ischaemia as defined by the Trans-Atlantic Inter-Society Consensus II guidelines.
  • Active DFU in the contralateral limb, major amputation (below or above the knee) of the contralateral limb.
  • Soft tissue infection.
  • Untreated diabetic foot osteomyelitis.
  • Need for walking aids.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diabetic Foot Unit. Universidad Complutense de Madrid

Madrid, Madrid, 28040, Spain

Location

Related Publications (1)

  • Lazaro-Martinez JL, Garcia-Madrid M, Molines-Barroso RJ, Alvaro-Afonso FJ, Tardaguila-Garcia A, Lopez-Moral M. Clinical Efficacy of a Novel Minimal Offloading Dressing for the Treatment of Plantar Diabetes-Related Foot Ulcers: A Pilot Randomized Controlled Clinical Trial. Adv Skin Wound Care. 2026 Apr 1;39(3):152-158. doi: 10.1097/ASW.0000000000000413. Epub 2026 Feb 19.

MeSH Terms

Conditions

Diabetic FootFoot Ulcer

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic NeuropathiesFoot Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

December 7, 2024

First Posted

December 11, 2024

Study Start

December 1, 2023

Primary Completion

September 1, 2024

Study Completion

September 30, 2024

Last Updated

December 17, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

IPD will be shared if asked from any institution

Locations